9 results on '"Barbaud A"'
Search Results
2. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions.
- Author
-
Barbaud, A., Trechot, P., Reichert-Penetrat, S., Commun, N., and Schmutz, J. L.
- Subjects
- *
SKIN tests , *DRUGS , *ALLERGIES - Abstract
Skin tests with drugs can be of value in investigating patients who have developed cutaneous adverse drug reactions (CADR), but their specificity and relevance remain to be determined. A false-positive result on skin testing can happen if it is not compared to results in control subjects. When performing intradermal tests (IDT), we have determined the lowest concentrations that induce false-positive results for many drugs, including betalactam antibiotics, cephalosporins, other antibiotics or non-steroidal anti-inflammatory drugs. Some drugs in their commercialized form contain sodium lauryl sulfate and can induce irritation when patch tested as such. When patch tested with colchicine at 10% in pet. or with a Cytotec® pill (containing misoprostol) at 30% in pet., respectively, 80% of the 29 and 9 of the 10 negative controls developed false-positive results. Lastly, positive results of patch tests with drugs can be related to contact allergy to one of the components of the commercialized form of the drug, without any relevance to the investigation of a CADR, as observed in 2 cases with iodine or avocado oil. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
3. A new entity: the neutrophilic fixed food eruption.
- Author
-
Waton, Julie, Splingard, Barthelemy, and Barbaud, Annick
- Subjects
- *
CASE studies , *FRESHWATER fishes , *FOREARM injuries , *SEAFOOD , *ALLERGIES , *PHYSIOLOGY - Abstract
The article presents a case study of a 26-year-old male cook who was presented due to fixed eruption caused by contact or ingestion of freshwater fish and seafood. It states that bullous lesions appear on his forearms when he handles or eat fish. It mentions that normal skin on the forearm had underwent prick tests with commercial extracts or fresh food. Meanwhile, it mentions that the case will be classified as neutrophilic fixed food eruption.
- Published
- 2011
- Full Text
- View/download PDF
4. Occurrence of immediate and delayed hypersensitivity to hexamidine.
- Author
-
Le Seac'h, Agathe, Castagna, Julie, Chantran, Yannick, Kurihara, Flore, Amsler, Emmanuelle, Soria, Angèle, and Barbaud, Annick
- Subjects
- *
DELAYED hypersensitivity , *ALLERGIES , *ECZEMA , *URTICARIA , *ANAPHYLAXIS , *ALLERGIC rhinitis , *ATOPIC dermatitis - Abstract
(C) Positive prick test with undiluted Desomedine on delayed reading at day 2 (same prick test as in B) gl Prick tests were performed with undiluted Desomedine (hexamidine 0.1%), and these confirmed both immediate and delayed type hypersensitivity on immediate (Figure 1B) and delayed readings on day (D)2 (Figure 1C). Although allergic contact dermatitis in response to antiseptics is common, we should be aware that occasionally this may co-exist with immediate-type hypersensitivity, and also with molecules frequently sold over the counter. Keywords: case report; delayed hypersensitivity; hexamidine; immediate hypersensitivity EN case report delayed hypersensitivity hexamidine immediate hypersensitivity 580 582 3 10/22/21 20211101 NES 211101 CASE REPORT A 66-year-old man with a history of arterial hypertension (treated by dietary approaches only), allergic rhinitis, asthma, and atopic dermatitis, developed a grade II anaphylactic reaction 5 minutes after the first intranasal application of hexamidine (Desomedine, Chauvin Bausch & Lomb laboratory, Montpellier, France) for a cold. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
5. Tert‐butylhydroquinone is a marker for sensitivity to Nigella sativa oil allergy: Five new cases.
- Author
-
Seiller, Hélène, Kurihara, Flore, Chasset, François, Soria, Angèle, and Barbaud, Annick
- Subjects
- *
BLACK cumin , *ECZEMA , *ALLERGIES , *PETROLEUM , *TUMOR suppressor genes , *VEGETABLE oils - Abstract
Thereby, the similar patch test profile results in our five patients support the hypothesis that TBHQ is a good marker for NSO allergy through a TQ sensitization. Keywords: allergic contact dermatitis; Cas number 1948-33-0; patch test; Nigella sativa oil; tert-butylhydroquinone; thymoquinone EN allergic contact dermatitis Cas number 1948-33-0 patch test Nigella sativa oil tert-butylhydroquinone thymoquinone 447 449 3 05/06/21 20210601 NES 210601 Use of complementary and alternative medicine has increased in industrialized countries.1,2 I Nigella sativa i oil (NSO), used as an herbal medicine for thousands of years, has drawn interest for its immunoregulatory, antimicrobial, cardiovascular, and antitumoral properties.3 Although patients expect alternative medicine to be safe,4 allergic contact dermatitis (ACD) and bullous dermatitis with NSO have been reported.5,6 The hypothesis that thymoquinone (TQ), its major component, is the causative substance of allergic reaction to NSO was proposed,7 but thymoquinone is not yet available in France for patch tests. These five cases and the previously published one support the hypothesis that due to chemical similarities with TQ, which is supposed to be the responsible for NSO sensitization, TBHQ would be a good marker for NSO allergy. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
6. Contact sensitization to modern dressings: a multicentre study on 354 patients with chronic leg ulcers.
- Author
-
Valois, Aude, Waton, Julie, Avenel‐Audran, Martine, Truchetet, François, Collet, Evelyne, Raison‐Peyron, Nadia, Cuny, Jean Francois, Bethune, Benjamin, Schmutz, Jean Luc, and Barbaud, Annick
- Subjects
- *
ALLERGIES , *ALLERGENS , *SURGICAL dressings , *CONTACT dermatitis , *SKIN inflammation ,LEG ulcers - Abstract
Background Modern dressings ( MDs) may have a low sensitization rate, but there is a lack of prospective studies in patients with chronic leg ulcers ( CLUs) to evaluate this. Objectives To determine the rate of sensitization (contact allergy) to MDs and substances present in dressings. Patients and methods A prospective multicentre study was carried out in patients with CLUs at five French dermatology departments; patch tests were performed with the European baseline series and with an additional 27 individual allergens and 10 MDs. Results Among 354 patients (226 women and 128 men) with CLUs, 59.6% had at least one positive patch test reaction to an MD and 19% had at least one sensitization to an MD. The number of positive test reactions per patient was correlated with the duration of ulcerative disease, but not with ulcer duration, the cause of the ulcer, or the presence of surrounding eczematous lesions. For 11 of 45 patients sensitized to Ialuset cream®, more detailed information could be obtained with sensitization to sodium dehydroacetate (5 cases) or Lanette SX® (3 cases). Conclusions Sensitization to MDs is not rare. It is absolutely necessary to label all components of MDs on their packaging and to avoid some sensitizing molecules, such as colophonium derivatives or any strong sensitizers. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Outbreak of contact sensitization to methylisothiazolinone: an analysis of French data from the REVIDAL-GERDA network.
- Author
-
Hosteing, Stéphanie, Meyer, Nicolas, Waton, Julie, Barbaud, Annick, Bourrain, Jean‐Luc, Raison‐Peyron, Nadia, Felix, Brigitte, Milpied‐Homsi, Brigitte, Ferrier Le Bouedec, Marie‐Christine, Castelain, Michel, Vital‐Durand, Dominique, Debons, Michèle, Collet, Evelyne, Avenel‐Audran, Martine, Mathelier‐Fusade, Pascale, Vermeulen, Christophe, Assier, Haudrey, Gener, Gwendoline, Lartigau‐Sezary, Isabelle, and Catelain‐Lamy, Amandine
- Subjects
- *
SKIN inflammation , *IMMUNOLOGIC diseases , *ALLERGENS , *ANTIGENS , *ALLERGIES - Abstract
Background The preservative methylisothiazolinone ( MI) is used in combination with methylchloroisothiazolinone ( MCI), but the MCI/MI mixture has been identified as highly allergenic. MI is considered to be less allergenic, and since the mid-2000s has been widely used alone, but is now clearly identified as a contact allergen. The French Vigilance Network for Dermatology and Allergy of the Study and Research Group on Contact Dermatitis ( REVIDAL-GERDA) added MI to its baseline patch testing series in 2010. Objective To evaluate the change in the proportion of MI-positive tests in France between 2010 and 2012. Patients/materials/methods We conducted a nationwide, multicentre, retrospective study of all MI-tested patients between 2010 and 2012. Results Sixteen centres participated in the study (7874 patients were tested). Patch tests were performed mainly at a concentration of MI 200 ppm aq. We observed a significant increase in the proportion of MI-positive tests in 2012 and 2011 as compared with 2010 (5.6%, 3.3%, and 1.5%, respectively; p < 0.001). Conclusions We report a significant increase in the number of MI-positive tests. MI is confirmed to be a rapidly emerging allergen, as also observed in other European countries. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Is 500 ppm a better concentration than 200 ppm for diagnosing contact allergy to methylisothiazolinone?
- Author
-
Waton, Julie, Poreaux, Claire, Schmutz, Jean Luc, and Barbaud, Annick
- Subjects
- *
CONTACT dermatitis diagnosis , *ALLERGIES , *SKIN infections , *CHEMICAL reactions , *SKIN inflammation diagnosis , *PATIENTS - Abstract
The article presents a case study of patients with contact dermatitis, who underwent patch testing with the European baseline. It compares the efficiency of a 550 parts per million (ppm) concentration of methylisothiazolinone (MI) for contact allergy diagnosis with a 220ppm solution. It says that the low rate of positive patch test reactions indicate that the patch tests are not irritant.
- Published
- 2013
- Full Text
- View/download PDF
9. Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.
- Author
-
Bursztejn, A. C., Tréchot, Ph., Cuny, J. F., Schmutz, J. L., and Barbaud, A.
- Subjects
- *
DRUG therapy , *ANTINEOPLASTIC agents , *DRUGS , *CANCER treatment , *ALLERGIES , *PATIENTS - Abstract
Cutaneous adverse drug reactions (CADR) during chemotherapy are not rare, but difficult to manage. Case 1, a 49-year-old man was treated with 5-fluorouracil, irinotecan, and oxaliplatin for a pancreatic tumour. He developed a generalized urticaria during his seventh course of chemotherapy. 2 months later, skin tests determined a granisetron allergy with an ondansetron cross-reaction. Substituting the anti-emetic allowed continuation of the chemotherapy. Case 2, a 44-year-old woman, having recurring breast cancer that was treated with doxorubicin, and docetaxel developed a maculo-papular rash (MPR) the day after the first chemotherapy treatment. 2 weeks later, skin tests determined a corticosteroid class A allergy. Using a class C corticosteroid, no other reaction occurred. Case 3, a 44-year-old woman, having breast cancer treated with 5-fluorouracil, cyclophosphamide, and epirubicin developed an MPR after the second chemotherapy treatment. 12 days later, skin tests showed a granisetron allergy. Using alizapride, chemotherapy was continued with no further reaction. CADR necessitate a thorough investigation, modified according to the patient’s chemotherapy treatment chronology and precautions while testing the molecules. Tests are rarely carried out, however, these tests allow for continuation of effective chemotherapy once the responsible agent has been determined. The 3 cases reported underline the role of complementary treatment and the necessity to test those molecules. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.